Haemonetics Corp. buy Robert W. Baird
Start price
15.12.25
/
50%
€67.50
Target price
15.12.26
€84.33
Performance (%)
-26.81%
Price
02.04.26
€49.40
Summary
This prediction is currently active. The price of Haemonetics Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.81%. This prediction currently runs until 15.12.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -5.000% | -5.000% |
| iShares Core DAX® | 2.489% | -5.941% |
| iShares Nasdaq 100 | 1.649% | -2.462% |
| iShares Nikkei 225® | 0.555% | -7.597% |
| iShares S&P 500 | 1.347% | -2.943% |
Comments by Robert_W__Baird for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) was given a new $99.00 price target on by analysts at Robert W. Baird. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Robert_W__Baird for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€62.50
26.06.25
26.06.25
€74.44
26.06.26
26.06.26
-22.88%
02.04.26
02.04.26
